BioMarin Pharmaceutical (BMRN)

Nasdaq Health Care Biotechnology S&P MidCap 400

$56.03

-0.09 (-0.16%)

Close of Nov 06, 2026 · end-of-day data

Source: BioMarin Pharmaceutical's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 04, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$1.12B	$1.31B	$1.49B	$1.70B	$1.86B	$1.85B	$2.10B	$2.42B	$2.85B	$3.22B
Cost of revenue	$209.62M	$241.79M	$315.26M	$359.47M	$524.27M	$470.51M	$503.02M	$532.06M	$580.24M	$717.44M
Gross profit	$907.23M	$1.07B	$1.18B	$1.34B	$1.34B	$1.38B	$1.59B	$1.89B	$2.27B	$2.50B
Research & development	$661.90M	$610.75M	$696.33M	$715.01M	$628.12M	$628.79M	$649.61M	$746.77M	$747.18M	$921.93M
Selling, general & admin	$476.59M	$554.34M	$604.35M	$680.92M	$737.67M	$759.38M	$823.24M	$892.41M	$1.01B	$1.15B
Operating income	-$803.43M	-$14.70M	-$123.52M	-$100.46M	-$43.44M	-$82.34M	$160.97M	$185.77M	$484.21M	$409.48M
Interest expense	$39.50M	$42.71M	$43.66M	$23.46M	$29.31M	$15.34M	$15.97M	$17.34M	$12.67M	$10.90M
Pre-tax income	-$831.05M	-$35.88M	-$142.71M	-$94.81M	-$49.00M	-$75.35M	$149.58M	$188.56M	$541.76M	$482.48M
Income tax	-$200.84M	$81.17M	-$65.49M	-$70.96M	-$903.03M	-$11.27M	$8.02M	$20.92M	$114.90M	$133.58M
Net income	-$630.21M	-$117.04M	-$77.21M	-$23.85M	$854.03M	-$64.08M	$141.56M	$167.65M	$426.86M	$348.90M
EBITDA	-$706.52M	$73.16M	-$27.85M	$4.84M	$61.73M	$25.70M	$262.94M	$290.16M	$580.64M	$489.04M
EPS (basic)	$-3.80	$-0.67	$-0.44	$-0.13	$4.72	$-0.35	$0.76	$0.89	$2.25	$1.82
EPS (diluted)	$-3.81	$-0.67	$-0.44	$-0.13	$4.50	$-0.35	$0.75	$0.87	$2.21	$1.80
Diluted shares	166.22M	174.43M	177.27M	179.04M	191.68M	182.85M	188.96M	191.59M	196.71M	197.39M
Gross margin	81.2%	81.6%	78.9%	78.9%	71.8%	74.5%	76.0%	78.0%	79.7%	77.7%
Operating margin	-71.9%	-1.1%	-8.3%	-5.9%	-2.3%	-4.5%	7.7%	7.7%	17.0%	12.7%
Net margin	-56.4%	-8.9%	-5.2%	-1.4%	45.9%	-3.5%	6.8%	6.9%	15.0%	10.8%

Balance sheet

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$408.33M	$598.03M	$493.98M	$437.45M	$649.16M	$587.28M	$724.53M	$755.13M	$942.84M	$1.31B
Short-term investments	$381.35M	$797.94M	$590.33M	$316.36M	$416.23M	$426.60M	$567.01M	$318.68M	$194.86M	$248.93M
Receivables	$215.28M	$261.37M	$342.63M	$377.40M	$448.35M	$373.40M	$461.32M	$633.70M	$660.53M	$908.21M
Inventory	$355.13M	$475.77M	$530.87M	$680.27M	$698.55M	$776.67M	$894.08M	$1.11B	$1.23B	$1.30B
Total current assets	$1.42B	$2.21B	$2.06B	$1.94B	$2.34B	$2.27B	$2.75B	$2.96B	$3.23B	$3.95B
Goodwill	$197.04M	$197.04M	$197.04M	$197.04M	$196.20M	$196.20M	$196.20M	$196.20M	$196.20M	$196.20M
Total assets	$4.02B	$4.63B	$4.43B	$4.69B	$5.85B	$6.00B	$6.38B	$6.84B	$6.99B	$7.59B
Total current liabilities	$439.31M	$816.52M	$523.24M	$932.50M	$492.55M	$546.50M	$588.88M	$1.18B	$606.99M	$759.03M
Short-term debt	—	—	—	—	—	—	—	—	—	$0
Long-term debt	—	—	—	—	—	—	—	—	—	$597.18M
Total debt	—	—	—	—	—	—	—	—	—	$597.18M
Total liabilities	$1.26B	$1.82B	$1.46B	$1.57B	$1.74B	$1.74B	$1.77B	$1.89B	$1.33B	$1.51B
Shareholders' equity	$2.77B	$2.81B	$2.97B	$3.12B	$4.10B	$4.27B	$4.60B	$4.95B	$5.66B	$6.09B

Cash flow

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	-$227.84M	-$8.76M	$20.21M	$48.26M	$85.36M	$304.54M	$175.90M	$159.26M	$572.84M	$827.99M
Capital expenditures	$148.38M	$199.22M	$144.62M	$145.03M	$114.31M	$95.58M	$120.96M	$96.69M	$85.42M	$103.04M
Free cash flow	-$376.22M	-$207.98M	-$124.41M	-$96.76M	-$28.95M	$208.96M	$54.94M	$62.57M	$487.42M	$724.96M
Investing cash flow	-$484.05M	-$305.46M	$264.35M	-$31.03M	-$53.62M	-$366.31M	-$20.03M	-$111.24M	$136.49M	-$414.24M
Financing cash flow	$727.11M	$507.14M	-$388.01M	-$74.67M	$181.12M	-$48.00K	-$18.65M	-$18.73M	-$526.45M	-$42.39M
Share buybacks	—	—	$0	$0	$50.00M	$0	$0	—	—	—
Stock-based compensation	$134.64M	$140.26M	$148.82M	$159.87M	$189.71M	$197.26M	$196.31M	$207.10M	$201.57M	$181.41M
Depreciation & amortization	$96.91M	$87.86M	$95.67M	$105.30M	$105.17M	$108.04M	$101.97M	$104.39M	$96.43M	$79.56M

Income statement

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	$646.21M	$648.83M	$712.03M	$745.74M	$747.31M	$745.14M	$825.41M	$776.13M	$874.57M	$766.21M	$989.71M	$1.02B
Cost of revenue	$137.93M	$125.18M	$130.46M	$188.46M	$136.14M	$151.56M	$150.09M	$140.09M	$275.71M	$195.00M	$202.79M	$205.42M
Gross profit	$508.28M	$523.65M	$581.57M	$557.28M	$611.17M	$593.59M	$675.32M	$636.05M	$598.86M	$571.21M	$786.91M	$819.23M
Research & development	$206.25M	$204.99M	$183.79M	$184.90M	$173.51M	$158.73M	$161.31M	$409.48M	$192.41M	$178.80M	$206.95M	$180.53M
Selling, general & admin	$259.51M	$225.91M	$263.03M	$253.48M	$266.61M	$206.12M	$232.28M	$268.42M	$446.21M	$258.29M	$395.55M	$333.64M
Operating income	$27.28M	$88.46M	$120.45M	$113.89M	$161.41M	$223.89M	$276.89M	-$46.69M	-$44.61M	$129.64M	$110.92M	-$82.08M
Interest expense	$6.10M	$3.55M	$3.57M	$2.97M	$2.58M	$2.39M	$2.39M	$2.39M	$2.78M	$9.57M	$60.73M	$55.23M
Pre-tax income	$19.33M	$105.55M	$132.14M	$134.44M	$169.64M	$238.09M	$297.87M	-$26.32M	-$27.15M	$141.20M	$61.38M	-$131.77M
Income tax	-$1.05M	$16.89M	$24.96M	$28.36M	$44.70M	$52.40M	$57.34M	$4.42M	$19.42M	$35.68M	$16.62M	-$8.94M
Net income	$20.38M	$88.66M	$107.17M	$106.08M	$124.94M	$185.69M	$240.53M	-$30.74M	-$46.57M	$105.53M	$44.76M	-$122.83M
EBITDA	$54.14M	$115.81M	$146.91M	$132.90M	$185.01M	$245.96M	$295.45M	-$28.20M	-$24.17M	$146.05M	$208.56M	$48.38M
EPS (basic)	$0.11	$0.47	$0.56	$0.56	$0.66	$0.97	$1.25	$-0.16	$-0.24	$0.55	$0.23	$-0.63
EPS (diluted)	$0.10	$0.46	$0.55	$0.55	$0.65	$0.95	$1.23	$-0.16	$-0.24	$0.54	$0.23	$-0.63
Diluted shares	-3.45M	199.26M	200.50M	197.15M	25.00K	196.47M	197.09M	192.03M	501.00K	197.67M	194.47M	193.59M
Gross margin	78.7%	80.7%	81.7%	74.7%	81.8%	79.7%	81.8%	82.0%	68.5%	74.6%	79.5%	80.0%
Operating margin	4.2%	13.6%	16.9%	15.3%	21.6%	30.0%	33.5%	-6.0%	-5.1%	16.9%	11.2%	-8.0%
Net margin	3.2%	13.7%	15.1%	14.2%	16.7%	24.9%	29.1%	-4.0%	-5.3%	13.8%	4.5%	-12.0%

Balance sheet

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Cash & equivalents	$755.13M	$747.00M	$972.15M	$675.45M	$942.84M	$1.05B	$1.21B	$1.25B	$1.31B	$2.22B	$874.00M	$736.01M
Short-term investments	$318.68M	$299.58M	$252.20M	$255.00M	$194.86M	$223.53M	$218.31M	$227.73M	$248.93M	$0	$0	$0
Receivables	$633.70M	$637.16M	$691.23M	$777.55M	$660.53M	$739.18M	$855.86M	$790.27M	$908.21M	$903.91M	$1.06B	$1.08B
Inventory	$1.11B	$1.14B	$1.18B	$1.18B	$1.23B	$1.27B	$1.34B	$1.38B	$1.30B	$1.27B	$1.78B	$1.80B
Total current assets	$2.96B	$2.99B	$3.26B	$3.06B	$3.23B	$3.47B	$3.81B	$3.85B	$3.95B	$4.61B	$3.97B	$3.92B
Goodwill	$196.20M	$196.20M	$196.20M	$196.20M	$196.20M	$196.20M	$196.20M	$196.20M	$196.20M	$196.20M	$655.75M	$666.37M
Total assets	$6.84B	$6.87B	$7.07B	$6.85B	$6.99B	$7.15B	$7.46B	$7.61B	$7.59B	$8.59B	$11.72B	$11.57B
Total current liabilities	$1.18B	$1.09B	$1.07B	$715.66M	$606.99M	$628.21M	$684.25M	$798.44M	$759.03M	$793.15M	$1.66B	$1.60B
Short-term debt	—	—	—	—	—	—	—	—	$0	—	$658.20M	$658.72M
Long-term debt	—	—	—	—	—	—	—	—	$597.18M	$1.43B	$3.53B	$3.51B
Total debt	—	—	—	—	—	—	—	—	$597.18M	$1.43B	$4.19B	$4.17B
Total liabilities	$1.89B	$1.80B	$1.78B	$1.44B	$1.33B	$1.35B	$1.43B	$1.56B	$1.51B	$2.38B	$5.40B	$5.31B
Shareholders' equity	$4.95B	$5.07B	$5.29B	$5.41B	$5.66B	$5.79B	$6.03B	$6.06B	$6.09B	$6.21B	$6.32B	$6.26B

Cash flow

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Operating cash flow	$27.48M	$46.97M	$118.76M	$221.48M	$185.63M	$174.39M	$185.27M	$368.69M	$99.64M	$220.65M	$168.11M	$188.21M
Capital expenditures	$28.92M	$26.10M	$21.33M	$18.46M	$19.53M	$16.77M	$17.10M	$28.45M	$40.72M	$20.92M	$28.82M	$28.29M
Free cash flow	-$1.43M	$20.87M	$97.44M	$203.02M	$166.10M	$157.63M	$168.17M	$340.24M	$58.92M	$199.73M	$139.29M	$159.92M
Investing cash flow	-$64.96M	-$14.24M	$90.48M	-$16.16M	$76.40M	-$28.24M	-$12.59M	-$330.96M	-$42.45M	$725.53M	-$5.10B	-$306.90M
Financing cash flow	$10.84M	-$42.79M	$12.61M	-$499.12M	$2.86M	-$38.78M	-$4.60M	-$2.17M	$3.16M	$813.17M	$2.74B	-$18.83M
Stock-based compensation	$54.85M	$58.25M	$47.91M	$43.49M	$51.92M	$37.70M	$47.53M	$49.27M	$46.91M	$43.46M	$75.69M	$53.53M
Depreciation & amortization	$26.86M	$27.35M	$26.46M	$19.01M	$23.61M	$22.07M	$18.56M	$18.49M	$20.44M	$16.41M	$97.64M	$130.47M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.